HABRI Central - Resources: Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone: About

The Human Animal Bond Research Institute (HABRI) is issuing a call for research proposals from institutions and organizations across the globe to investigate the health outcomes of pet ownership and/or animal-assisted interventions (AAI), both for the people and the animals involved. To learn more, visit https://habri.org/grants/funding-opportunities/ close

 
You are here: Home / Journal Articles / Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone / About

Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone

By W. Gordon Frankle, Ilise Lombardo, Lawrence S. Kegeles, Mark Slifstein, John H. Martin, Yiyun Huang, Dah-Ren Hwang, Elisa Reich, Claudine Cangiano, Roberto Gil, Anissa Abi-Dargham, Marc Laruelle

View Resource (HTM)

Licensed under

Category Journal Articles
Date 2011
Publication Title Journal of Psychopharmacology
Volume 25
Issue 6
Pages 734-743
ISBN/ISSN 0269-8811 1461-7285
DOI 10.1177/0269881110388329
Author Address Frankle, W. Gordon, University of Pittsburgh, Department of Psychiatry and Radiology WPIC 3511 O
Cite this work

Researchers should cite this work as follows:
Tags
  1. Drug therapy
  2. pathophysiology
  3. patients
  4. peer-reviewed
  5. receptors
  6. schizophrenia
  7. serotonin
  8. tranquilizers
  9. treatment
Badges
  1. peer-reviewed